| Jennifer Sweet, DO | |
|
3021 Griffin Ave, Enumclaw, WA 98022-2369 | |
| (360) 825-6511 | |
| (360) 825-6536 |
| Full Name | Jennifer Sweet |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 11 Years |
| Location | 3021 Griffin Ave, Enumclaw, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548605926 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OP60643633 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chi Franciscan Health At Home | University place, WA | Home health agency |
| St Elizabeth Hospital | Enumclaw, WA | Hospital |
| St Joseph Medical Center | Tacoma, WA | Hospital |
| St Francis Community Hospital | Federal way, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Franciscan Medical Group | 0547173866 | 1115 |
News Archive
As countries worldwide face the challenge of managing the COVID-19 pandemic, Ultimaker is making its global network of 3D printing hubs, experts, and designers directly available to hospitals in need of tools and applications that are short in supply and can be quickly produced with 3D printing.
Although clots in the lung (pulmonary embolism or PE) are the second-leading cause of sudden death in the United States, blood tests and ultrafast CT scanning to detect PE are being used on so many patients that over 90% of these tests are negative.
Celsis In Vitro, Inc. announced today that the United States District Court for the Northern District of Illinois in Chicago has entered a preliminary injunction against CellzDirect Inc., Invitrogen Corporation, and Life Technologies (the Defendants) due to their infringement of U.S. Patent No. 7,604,929 (the Liverpool™ patent).
A compound found in breast milk, named fibroblast growth factor 21 (FGF21), plays a key role in neonatal nutrient absorption and intestinal function. FGF21 also contributes to improve newborn growth and metabolic profile.
› Verified 7 days ago
| Entity Name | Franciscan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093165334 PECOS PAC ID: 0547173866 Enrollment ID: O20031111000789 |
News Archive
As countries worldwide face the challenge of managing the COVID-19 pandemic, Ultimaker is making its global network of 3D printing hubs, experts, and designers directly available to hospitals in need of tools and applications that are short in supply and can be quickly produced with 3D printing.
Although clots in the lung (pulmonary embolism or PE) are the second-leading cause of sudden death in the United States, blood tests and ultrafast CT scanning to detect PE are being used on so many patients that over 90% of these tests are negative.
Celsis In Vitro, Inc. announced today that the United States District Court for the Northern District of Illinois in Chicago has entered a preliminary injunction against CellzDirect Inc., Invitrogen Corporation, and Life Technologies (the Defendants) due to their infringement of U.S. Patent No. 7,604,929 (the Liverpool™ patent).
A compound found in breast milk, named fibroblast growth factor 21 (FGF21), plays a key role in neonatal nutrient absorption and intestinal function. FGF21 also contributes to improve newborn growth and metabolic profile.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Sweet, DO 3021 Griffin Ave, Enumclaw, WA 98022-2369 Ph: (360) 825-6511 | Jennifer Sweet, DO 3021 Griffin Ave, Enumclaw, WA 98022-2369 Ph: (360) 825-6511 |
News Archive
As countries worldwide face the challenge of managing the COVID-19 pandemic, Ultimaker is making its global network of 3D printing hubs, experts, and designers directly available to hospitals in need of tools and applications that are short in supply and can be quickly produced with 3D printing.
Although clots in the lung (pulmonary embolism or PE) are the second-leading cause of sudden death in the United States, blood tests and ultrafast CT scanning to detect PE are being used on so many patients that over 90% of these tests are negative.
Celsis In Vitro, Inc. announced today that the United States District Court for the Northern District of Illinois in Chicago has entered a preliminary injunction against CellzDirect Inc., Invitrogen Corporation, and Life Technologies (the Defendants) due to their infringement of U.S. Patent No. 7,604,929 (the Liverpool™ patent).
A compound found in breast milk, named fibroblast growth factor 21 (FGF21), plays a key role in neonatal nutrient absorption and intestinal function. FGF21 also contributes to improve newborn growth and metabolic profile.
› Verified 7 days ago
Kashish Goyal, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3021 Griffin Ave, Enumclaw, WA 98022 Phone: 360-825-6511 Fax: 253-274-7991 | |
Dr. Tanya Marie Wilke, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1427 Jefferson Ave, Suite 202, Enumclaw, WA 98022 Phone: 360-825-2849 Fax: 360-825-5381 | |
Dr. Eduardo Visitacion Duquez Jr., M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3021 Griffin Ave, Enumclaw, WA 98022 Phone: 360-825-6511 Fax: 253-274-7993 | |
James A Merrill, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3021 Griffin Ave, Enumclaw, WA 98022 Phone: 360-825-6511 | |
James E Clark, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3021 Griffin Ave, Enumclaw, WA 98022 Phone: 360-825-6511 Fax: 360-825-6536 | |
Dr. Dane Bay, M.D., M.P.H. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3021 Griffin Ave, Enumclaw, WA 98022 Phone: 360-825-6511 Fax: 253-272-0419 | |
Daniel T Clerc, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3021 Griffin Ave, Enumclaw, WA 98022 Phone: 360-825-6511 Fax: 360-825-6536 |